INSMED Inc
INSMFigures shown here come from public SEC filings. Dates beside each section show the available history.
How INSMED Inc Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 17 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 26, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among INSMED Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-05-13 · Lewis William: Larger than 132 of the 144 other insider sales of Common Stock on file. SEC filing
- 2026-05-11 · Flammer Martina M.D.: Larger than 130 of the 144 other insider sales of Common Stock on file. SEC filing
- 2026-04-01 · Adsett Roger: Larger than 137 of the 144 other insider sales of Common Stock on file. SEC filing
- 2026-04-01 · Adsett Roger: Larger than all 144 other insider sales of Common Stock on file. SEC filing
- 2026-03-30 · Smith Michael Alexander: Larger than 139 of the 144 other insider sales of Common Stock on file. SEC filing
- 2026-02-24 · Smith Michael Alexander: Larger than 135 of the 144 other insider sales of Common Stock on file. SEC filing
- 2026-01-02 · Schaeffer Orlov S Nicole: Larger than 143 of the 144 other insider sales of Common Stock on file. SEC filing
- 2026-01-02 · Schaeffer Orlov S Nicole: Larger than 142 of the 144 other insider sales of Common Stock on file. SEC filing
- 2026-01-02 · Schaeffer Orlov S Nicole: Larger than 131 of the 144 other insider sales of Common Stock on file. SEC filing
- 2025-12-05 · SHAROKY MELVIN MD: Larger than 140 of the 144 other insider sales of Common Stock on file. SEC filing
- 2025-11-17 · LEE LEO: Larger than 136 of the 144 other insider sales of Common Stock on file. SEC filing
- 2025-11-17 · LEE LEO: Larger than 133 of the 144 other insider sales of Common Stock on file. SEC filing
- 2025-11-17 · LEE LEO: Larger than 141 of the 144 other insider sales of Common Stock on file. SEC filing
- 2025-11-17 · LEE LEO: Larger than 134 of the 144 other insider sales of Common Stock on file. SEC filing
- 2025-11-12 · Schaeffer Orlov S Nicole: Larger than 138 of the 144 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-25 | Lewis William · Chair and CEO | Common Stock | S — Open market or private sale | −1,836 | 103.10 | SEC filing |
| 2026-06-25 | Lewis William · Chair and CEO | Common Stock | S — Open market or private sale | −3,723 | 104.28 | SEC filing |
| 2026-06-25 | Lewis William · Chair and CEO | Common Stock | S — Open market or private sale | −2,456 | 105.27 | SEC filing |
| 2026-06-25 | Lewis William · Chair and CEO | Common Stock | S — Open market or private sale | −1,292 | 106.27 | SEC filing |
| 2026-06-25 | Lewis William · Chair and CEO | Common Stock | S — Open market or private sale | −12,091 | 102.34 | SEC filing |
| 2026-06-22 | Smith Michael Alexander · Chief Legal Officer | Common Stock | S — Open market or private sale | −1,806 | 95.82 | SEC filing |
| 2026-06-08 | Lewis William · Chair and CEO | Common Stock | S — Open market or private sale | −6,515 | 94.03 | SEC filing |
| 2026-06-05 | Flammer Martina M.D. · Chief Medical Officer | Common Stock | S — Open market or private sale | −1,858 | 103.78 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-25 | Lewis William · Chair and CEO | Common Stock | M — Exercise or conversion of derivative security | +8,880 | SEC filing |
| 2026-06-25 | Lewis William · Chair and CEO | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −8,880 | SEC filing |
| 2026-06-25 | Lewis William · Chair and CEO | Common Stock | M — Exercise or conversion of derivative security | +12,518 | SEC filing |
| 2026-06-25 | Lewis William · Chair and CEO | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −12,518 | SEC filing |
| 2026-06-23 | Butera Samuele · SVP, GM, Global Respiratory | Stock Option (right to buy) | A — Grant, award, or other acquisition | +12,570 | SEC filing |
| 2026-06-23 | Butera Samuele · SVP, GM, Global Respiratory | Common Stock | A — Grant, award, or other acquisition | +7,342 | SEC filing |
| 2026-05-18 | Lewis William · Chair and CEO | Stock Option (right to buy) | M — Exercise or conversion of derivative security | −6,259 | SEC filing |
| 2026-05-18 | Lewis William · Chair and CEO | Common Stock | M — Exercise or conversion of derivative security | +4,440 | SEC filing |
Showing 8 of 26 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.